Iphase Technologies Pty Ltd

Status: Registered
Australian Company Number: 099531558
Australian Business Number: 33099531558
Registration date: 8th February 2002
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Iphase Technologies Pty Ltd is a limited by shares Australian proprietary company. Located at VIC 3150 since 2014-04-28 the company is, as the updated on 2014-04-29 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2002-02-08. Known company numbers for Iphase Technologies Pty Ltd are as follows: ACN - 099531558, Australian Business Number - 33099531558. This Australian proprietary company was previously located in VIC 3149 (from 2014-01-12 to 2014-04-28), VIC 3149 (from 2002-02-28 to 2014-01-12).

Details for ABN 33099531558

Type: Australian Private Company

ABN Status

Status From To
Active 8th February 2002 current

Main Name

Name From To
Iphase Technologies Pty Ltd 28th February 2002 current

Main Location

Location From To
VIC 3150 28th April 2014 current
VIC 3149 12th January 2014 28th April 2014
VIC 3149 28th February 2002 12th January 2014

Goods & Services Tax (GST)

Status From To
Registered 8th February 2002 current

Advertisements

Find company

VIC 3150 Location

2019 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2019 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2019, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.